PDPN and melanoma: Moreover, these novel findings are supported by other groups that identified the upregulation of PDPN as lymphatic anchorage marker by CHI3L1 in macrophages [65], as well as reduction in lymphatic spreading of B16-BL6 melanoma cells upon treatment with anti-CHI3L1 antibodies [39].